SynthesisBMC cardiovascular disorders2026
Prevalence of hypertension among adults in Nigeria: a systematic review and meta-analysis.
Synthesis in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Triglyceride-glucose index and abnormal blood pressure in adults aged over 70 years: real-world data evidence.BMC cardiovascular disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertension is a leading contributor to cardiovascular morbidity and mortality and a major driver of the noncommunicable disease burden in low- and middle-income countries. In Nigeria, prevalence estimates vary widely due to methodological heterogeneity across studies. We conducted a systematic review and meta-analysis to generate a current and geographically representative pooled estimate of hypertension prevalence among Nigerian adults.
objectivesTo estimate pooled prevalence of hypertension in Nigeria and examine subgroup differences.
methodsWe conducted a systematic review and meta-analysis of primarily cross-sectional studies to estimate the pooled prevalence of hypertension and examine subgroup differences (sex, settings, and geopolitical zones). Eligible studies were identified through comprehensive database searches and screened according to predefined inclusion criteria. Pooled estimates were calculated using a random-effects model to account for between-study variability. Seven databases (MEDLINE, EMBASE, Scopus, Web of Science, CINAHL, PsychInfo, and African Journals Online) were systematically searched for primary studies published from January 2015 to September 2025. Eligible studies measured hypertension among adult Nigerians 18 years and above as systolic blood pressure ≥ 140 mmHg or diastolic pressure ≥ 90 mmHg or on antihypertensive medication). Titles and abstracts were screened, data were extracted, and the quality of studies evaluated by two independent reviewers using the Newcastle-Ottawa Scale. Heterogeneity was assessed through Q-test, I2, tau2, and 95% prediction interval. Sensitivity analyses according to the potential sources of heterogeneity across the included studies were conducted.
resultsThirty-two studies comprising 49,788 participants were included. The pooled prevalence of hypertension was 34.2% (95% CI: 29.6, 39.1%), with substantial heterogeneity (I² = 99.1%; τ² = 0.367; 95% PI: 13–65%). Prevalence did not differ significantly between rural (34.4%) and urban (34.0%) settings (p = 0.175), males (41.6%) and females (32.3%) (p = 0.106), or across geopolitical zones (p = 0.148), although the South-West (41.7%) and North-Central (38.1%) regions showed higher point estimates.
conclusionHypertension affects approximately one in three Nigerian adults, indicating a substantial and widespread burden with regional variation but limited rural–urban or sex differences. These findings underscore the importance of sustained surveillance and context-specific strategies to address hypertension in Nigeria.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.